Psyence Group Inc. (CSE: PSYG) new CEO Dr. Neil Maresky joins Proactive to talk about his new appointment and his qualifications, including spending more than a decade at AstraZeneca Canada as Vice President of Scientific Affairs.
Maresky, a South African trained doctor, says he joined the psychedelics-focused life sciences group because of its ability to potentially impact mental health including depression, anxiety, PTSD, and end-of-life care.